Milica Pesic

Milica Pesic

Auto-generated profile, based on publicly available information

Milica Pesic

Clinic of Endocrinology, Diabetes and Metabolic Diseases, Clinical Center, Niš

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2011
Verified
Journal Article
Closed access
SRSaša P Radenković
Saša P Radenković
RKRadivoj D Kocić
Radivoj D Kocić
MPMilica M Pešić
Milica M Pešić
DDDragan N Dimić
Dragan N Dimić
MGMilena D Velojić Golubović
Milena D Velojić Golubović
VCVojislav M Cirić
Vojislav M Cirić

8 January 2007 in Surgical Practice
Verified
Journal Article
Closed access
PDF file
AKAleksandar Karanikolic
Aleksandar Karanikolic
MPMilica Pesic
Milica Pesic
NDNebojsa Djordjevic
Nebojsa Djordjevic
RKRadivoj Kocic
Radivoj Kocic
SRSasa Radenkovic
Sasa Radenkovic
DSDobrila Stankovic‐Djordjevic
Dobrila Stankovic‐Djordjevic

1 January 2011 in Vojnosanitetski Pregled
Verified
Journal Article
Open access
PDF file
MPMilica Pesic
Milica Pesic
DRDanijela Radojkovic
Danijela Radojkovic
SRSasa Radenkovic
Sasa Radenkovic
MSMirjana Spasic
Mirjana Spasic
SLStevo Lukic
Stevo Lukic
Background. Hypoparathyroidism refers to a group of disorders in which extracellular calcium levels cannot be maintained within the normal range due to relative or absolute deficiency of parathyroid hormone (PTH). The clinical features of hypoparathyroidism are consistent with hypocalcaemia and, predominantly, neuromuscular dysfunction. Although hypocalcaemia-induced seizures are well documented hypoparathyroidism-induced epilepsy is often misdiagnosed as idiopathic epilepsy. Case report. We reported a 57-year-old woman with new-onset seizure due to hypoparathyroidism. At first, diagnosis of epilepsy was established and the antiepileptic therapy was initiated with gradual increase of the dose. Computerized tomography scan of the head revealed bilateral basal ganglia and cerebellar calcification and many punctiform calcifications between cortical and subcortical parts. During hospitalization, laboratory tests showed hypocalcemia, hyperphosphatemia and low PTH level. Once the diagnosis of hypoparathyroidism was established, a proper treatment with calcium and vitamin D was started, and the patient was discharged from hospital with full seizure control. Conclusion. Standard evaluation of serum calcium levels in patients with new-onset epileptic seizures should be obligatory part of a diagnostic algoritam to avoid misdiagnosis of idiopathic epilepsy.

1 January 2007 in Archive of Oncology
Verified
Journal Article
Open access
DRDanijela Radojkovic
Danijela Radojkovic
SASlobodan Antic
Slobodan Antic
MPMilica Pesic
Milica Pesic
MRMilan Radojkovic
Milan Radojkovic
DBDijana Basic
Dijana Basic
TRTatjana Radjenovic-Petkovic
Tatjana Radjenovic-Petkovic
Background: The study was conducted to determine whether prolactin (PRL) influences radiological features of benign breast lesions. Methods: During the 4-year period, we observed 50 patients with nipple discharge: 23 with normal serum prolactin levels (group 1) and 27 with hyperprolactinemia (group 2a before hyperprolactinemia treatment and group 2b after hyperprolactinemia treatment). Patients observed during this study underwent breast ultrasonography (US) and mammography. Radiological findings in group 1, group 2a and group 2b were compared. Results: The most frequent radiological findings in group 2a were dilated lactiferous ducts and cystic lesions with statistical significances p

1 May 2015 in Endocrine Abstracts
Verified
Journal Article
Closed access
DRDanijela Radojkovic
Danijela Radojkovic
MPMilica Pesic
Milica Pesic
SRSasa Radenkovic
Sasa Radenkovic
SASlobodan Antic
Slobodan Antic
MNMarija Vukelic Nikolic
Marija Vukelic Nikolic
TSTatjana Jevtovic Stoimenov
Tatjana Jevtovic Stoimenov
Introduction: The aim of this study was to compare prolactin receptor gene (Prlr) expression in the duodenum, vertebra and kidney, during physiological and medicamentous hyperprolactinaemia. Methods: Wistar female rats 18 weeks old were divided into: Group P: nine rats, 3 week pregnant; Group M: ten rats that were intramuscular administrated Sulpirid (10 mg/kg) twice daily for 3 weeks; and age matched nulliparous rats as a control group: ten rats, 18 weeks old (C). Laboratory analysis included: prolactin, serum ionized calcium, phosphorus, urinary calcium and phosphorous excretion, and serum procollagen type 1 N-terminal propeptide (P1NP). Relative quantification of Prlr gene expression in duodenum, vertebra and kidney was determined by quantitative real time polymerase chain reaction. Results: PRL concentrations were significantly higher in group P and M, compared to C (P<0.001). In the pregnancy ionized calcium was significantly decreased compared to C and M (P<0.001); serum phosphorus was significantly increased compared to C (P<0.05); urinary calcium was increased compared to C (P<0.01) and lower compared to M (with no significance); urinary phosphorous was significantly increased compared to C and M (P<0.001) and P1NP was significantly increased compared to C and M (P<0.001). In the physiological hyperprolactinaemia expression of Prlr gene was significantly higher in the duodenum (P<0.001) and significantly lower in the vertebra (P<0.01). While down-regulation of Prlr gene was verified in the kidney, in both groups. Conclusions: In medicamentous hyperprolactinaemia, down-regulation of Prlr gene expression in duodenum could be underlying reason for diminished intestinal calcium absorption. Increased calcium uresis could be partly due to down-regulated Prlr gene expression in the kidney. In order to maintain calcium homeostasis, since intestinal absorption is compromised and loosing via kidney elevated, prolactin will rapidly take calcium from skeletal system, thank to increased Prlr gene expression in the vertebra, leading to more harmful effect on bone metabolism compering to physiological hyperprolactinaemia.

8 May 2018 in Endocrine Abstracts
Verified
Journal Article
Closed access
DRDanijela Radojkovic
Danijela Radojkovic
MPMilica Pesic
Milica Pesic
MRMilan Radojkovic
Milan Radojkovic
SKSonja Kostic
Sonja Kostic
SCSanja Curkovic
Sanja Curkovic
SASlobodan Antic
Slobodan Antic
Introduction: Adrenal incidentalomas (AI) are tumours revealed during radiological procedures in patients without previous suspicion for adrenal disease. This study was conducted to determine the frequency of functional AI. Patients and methods: Thirty-eight patients with AI were included in the study. The following parameters were considered: patient age, gender, size and location of the tumour, and radiological characteristics of adrenal masses. In order to determine hormonal activity of incidentalomas the following tests were done: basal cortisol values and day-night rhythm, adrenocorticotropic hormone (ACTH) overnight dexamethasone suppression test, vanillymandelic acid (VMA) in 24 h urine, electrolytes, haematocrit (HCT), acid-base status, oral glucose tolerance test (OGTT) and chromogranin A (CgA). Results: Patients consisted of 22 females (57.89%) and 16 males (42.1%) aged between 23 and 78. The highest incidence was in sixth decade (34.21%). Regarding the tumour localisation, 60.53% were found in the left ad-renal gland, 34.21% were visualised in the right, and 5.26% of the patients had bilaterally AI. The majority of analysed lesions were 1–4 cm in size (86.84%). Based on CT scans features, only two patients were highly suspicious of malignant AI. Hormonal evaluation showed that 32 patients (84.21%) had non-functional adrenal lesions. Among 6 patients with verified AI functional activity, 3 had pheochromocytomas, 2 were diagnosed as Cushing’s syndrome and one patient had aldosterone-producing adenoma. Adrenalectomy was performed in 9 patients. Histopathological examination confirmed suspected hormonal activity in 6 patients, adrenocortical carcinoma in one patient and secondary deposits due to bronchial carcinoma in one patient. Conclusion: Along with technology advances detection of AI is significantly increased. Two crucial tasks for physician are: 1. to distinguish functional from nonfunctional adrenal tumour and 2. to conclude whether it is benign or malignant one. Even though the frequency of functional AI is low and malignant AI even lower, thorough diagnostic procedures should be conducted in order to triage patients for surgical treatment.